$WLYW
Wally World Media Inc

2024 Q2 Form 10-Q Financial Statement

#000149315224020699 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $21.33K $8.090K
YoY Change 163.66% 14.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.289K $21.33K $8.089K
YoY Change 18.58% 163.7% 14.58%
Operating Profit -$8.289K -$21.33K -$8.089K
YoY Change 18.58% 163.7% 14.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$21.33K -$8.089K
YoY Change 163.69% 14.58%
Income Tax
% Of Pretax Income
Net Earnings -$8.289K -$21.33K -$8.089K
YoY Change 18.58% 163.7% 14.58%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 330.5M shares 330.5M shares 330.5M shares
Diluted Shares Outstanding 330.5M shares 330.5M shares 330.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $2.020K
YoY Change -100.0% -9.42%
Inventory
Prepaid Expenses $2.023K
Receivables
Other Receivables
Total Short-Term Assets $2.023K
YoY Change -9.28%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.023K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $2.023K
YoY Change -9.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.44K $20.16K $747.00
YoY Change 11737.88% 2598.26% 273.5%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $92.98K $80.00K
YoY Change 16.23% 76.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $121.4K $113.1K $80.75K
YoY Change 40.39% 40.12% 77.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $121.4K $113.1K $80.75K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $121.4K $113.1K $80.75K
YoY Change 40.39% 40.12% 77.07%
SHAREHOLDERS EQUITY
Retained Earnings -$15.86M -$15.85M -$15.82M
YoY Change 0.23% 0.22%
Common Stock $33.05K $33.05K $33.05K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$121.4K -$113.1K -$78.72K
YoY Change
Total Liabilities & Shareholders Equity $2.023K
YoY Change -9.28%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$8.289K -$21.33K -$8.089K
YoY Change 18.58% 163.7% 14.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$140.00 -$7.860K
YoY Change -98.22% 38.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0 7.860K
YoY Change -98.22% 38.14%
NET CHANGE
Cash From Operating Activities -140.0 -7.860K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 140.0 7.860K
Net Change In Cash 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$140.00 -$7.860K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
usd
CY2023Q3 us-gaap Assets
Assets
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
usd
CY2024Q1 us-gaap Assets
Assets
usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
330483033 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330483033 shares
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20156 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
495 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
92984 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90810 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
113140 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
91305 usd
CY2024Q1 us-gaap Liabilities
Liabilities
113140 usd
CY2023Q3 us-gaap Liabilities
Liabilities
91305 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
0 usd
CY2023Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
330483033 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
330483033 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
330483033 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
330483033 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
33048 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
33048 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15705814 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15705814 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15852002 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15830167 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-113140 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-91305 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21331 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8089 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21835 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18537 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
21331 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8089 usd
us-gaap Operating Expenses
OperatingExpenses
21835 usd
us-gaap Operating Expenses
OperatingExpenses
18537 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-21331 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8089 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21835 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18537 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21331 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8089 usd
us-gaap Net Income Loss
NetIncomeLoss
-21835 usd
us-gaap Net Income Loss
NetIncomeLoss
-18537 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330483033 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330483033 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330483033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330483033 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330483033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330483033 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330483033 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-70634 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8089 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-78723 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-60186 usd
us-gaap Net Income Loss
NetIncomeLoss
-18537 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-78723 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-91809 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21331 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-113140 usd
us-gaap Net Income Loss
NetIncomeLoss
-21835 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-113140 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-113140 usd
us-gaap Net Income Loss
NetIncomeLoss
-21835 usd
us-gaap Net Income Loss
NetIncomeLoss
-18537 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
836 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19661 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
549 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-91305 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-91305 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2174 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18824 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2174 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18824 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2174 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18824 usd
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p id="xdx_844_eus-gaap--ComparabilityOfPriorYearFinancialData_zTA8kwHcCPGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zy2jcZfgUvl7">Management’s Representation of Interim Financial Statements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These condensed financial statements should be read in conjunction with the audited financial statements and notes thereto at September 30, 2023 as presented in the Company’s Annual Report on Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15852002 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zriqK4G8bVC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_z9UF4UWEQyl4">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash
Cash
0 usd
CY2023Q3 us-gaap Cash
Cash
0 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
330483033 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
330483033 shares

Files In Submission

Name View Source Status
0001493152-24-020699-index-headers.html Edgar Link pending
0001493152-24-020699-index.html Edgar Link pending
0001493152-24-020699.txt Edgar Link pending
0001493152-24-020699-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wlyw-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
wlyw-20240331_cal.xml Edgar Link unprocessable
wlyw-20240331_def.xml Edgar Link unprocessable
wlyw-20240331_lab.xml Edgar Link unprocessable
wlyw-20240331_pre.xml Edgar Link unprocessable